More recently, we discovered that an enhancer element influencing CADM1 expression in the CADM1 promoter region in ATLL cells contains a nuclear factor-κB (NF-κB)-binding sequence and that CADM1 expression is dependent on activation of the canonical NF-κB pathway [13]. The gene discussed is NFKB1; the disease is adult T-cell leukemia/lymphoma.